ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical
Trending on TikTok(20,000+)

Melanotan II

Melanotan II

Also known as: MT-2, MT-II, Barbie Drug

Overview

Key Facts

Primary Goal: Research and therapeutic applications of Melanotan II

Activates MC1R to stimulate melanocyte melanin production. Activates MC3R and MC4R in the hypothalamus to modulate sexual arousal and appetite.

Dosing Information

Half-Life

~1-2 hours

Typical Dose

250–500 mcg

Frequency

Once daily during loading, then 1-2 times per week for maintenance

Cycle Length

7-14 day loading phase, then maintenance indefinitely or as needed

Administration Routes:
subcutaneous

Benefits

  • Rapid and pronounced skin tanning without UV exposure
  • Significant pro-erectile effects (originally studied for sexual dysfunction)
  • Appetite suppression and modest fat loss
  • Enhanced libido in both men and women
  • Photoprotective melanin increase

Side Effects

Nausea (very common, especially at higher doses)mild
Facial flushing and warmthmild
Spontaneous or prolonged erections (priapism risk)mild
Darkening of moles and nevi (requires dermatological monitoring)mild
Fatigue and yawningmild
Appetite suppression (may be unwanted)mild
Injection site sorenessmild

Mechanism of Action

1

Activates MC1R to stimulate melanocyte melanin production

2

Activates MC3R and MC4R in the hypothalamus to modulate sexual arousal and appetite

3

Increases cAMP in melanocytes leading to tyrosinase activation

4

Crosses the blood-brain barrier to exert central nervous system effects on libido

Contraindications

Do not use this peptide if any of the following apply:

  • History of melanoma or dysplastic nevus syndrome
  • Cardiovascular disease or uncontrolled hypertension
  • Priapism or conditions predisposing to priapism
  • Pregnancy or breastfeeding
  • Concurrent use of PDE5 inhibitors (increased priapism risk)

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

Developed at the University of Arizona in the 1990s, Melanotan II was initially researched for tanning and later for sexual dysfunction. Its pro-erectile effects led to the development of bremelanotide (PT-141), which received FDA approval. MT-II itself remains unregulated and is widely available through research chemical suppliers. Safety concerns centre around mole changes and potential melanoma promotion, though no causal link has been established. Regulatory agencies in Australia and Europe have issued warnings about unregulated use.

Frequently Asked Questions

Common questions about Melanotan II

UK-Specific Information

Exclusive data points and guidance for UK residents using Melanotan II

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok